Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 4, Pages 453-468
Publisher
Springer Nature
Online
2012-02-13
DOI
10.1007/s00262-012-1216-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer
- (2014) Zhiyong Liu et al. JOURNAL OF IMMUNOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Peroxiredoxin 1 Controls Prostate Cancer Growth through Toll-Like Receptor 4-Dependent Regulation of Tumor Vasculature
- (2011) J. R. Riddell et al. CANCER RESEARCH
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer
- (2011) N. Rigamonti et al. CLINICAL CANCER RESEARCH
- Immunosurveillance in human non-viral cancers
- (2011) Wolf Herman Fridman et al. CURRENT OPINION IN IMMUNOLOGY
- T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
- (2011) Moses K. Donkor et al. IMMUNITY
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
- (2011) Stephanie K. Watkins et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IDO Induces Expression of a Novel Tryptophan Transporter in Mouse and Human Tumor Cells
- (2011) J. D. Silk et al. JOURNAL OF IMMUNOLOGY
- Physiologic Control of IDO Competence in Splenic Dendritic Cells
- (2011) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Expanding Treatment Options for Metastatic Prostate Cancer
- (2011) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk-Based Management of Prostate Cancer
- (2011) Anthony V. D'Amico NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
- (2011) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
- (2011) Christopher U. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate Cancer in Men Less Than the Age of 50: A Comparison of Race and Outcomes
- (2011) Patrick M. Parker et al. UROLOGY
- Th17 cells: positive or negative role in tumor?
- (2010) Yuqiang Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concomitant Tumor and Minor Histocompatibility Antigen–Specific Immunity Initiate Rejection and Maintain Remission from Established Spontaneous Solid Tumors
- (2010) Rodrigo Hess Michelini et al. CANCER RESEARCH
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
- (2010) Jianghua Wang et al. CANCER RESEARCH
- Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center
- (2010) Igor Tsaur et al. CANCER SCIENCE
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
- (2010) B. C. Carthon et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cell heterogeneity and subset definition
- (2010) Elisa Peranzoni et al. CURRENT OPINION IN IMMUNOLOGY
- Current status of immunological therapies for prostate cancer
- (2010) Emmanuel S Antonarakis et al. CURRENT OPINION IN UROLOGY
- Possible roles of excess tryptophan metabolites in cancer
- (2010) King-Thom Chung et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
- (2010) Matteo Bellone et al. PLoS One
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model
- (2010) Eva Källberg et al. PROSTATE
- Dysfunctional Transforming Growth Factor- Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
- (2009) H. Pu et al. CANCER RESEARCH
- Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model
- (2009) S. Wada et al. CANCER RESEARCH
- Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination
- (2009) N. Grinshtein et al. CANCER RESEARCH
- Sulforaphane Inhibits Prostate Carcinogenesis and Pulmonary Metastasis in TRAMP Mice in Association with Increased Cytotoxicity of Natural Killer Cells
- (2009) S. V. Singh et al. CANCER RESEARCH
- Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
- (2009) L. Fong et al. CANCER RESEARCH
- Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
- (2009) X. Liu et al. CURRENT CANCER DRUG TARGETS
- Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
- (2009) Kathleen Ebelt et al. EUROPEAN JOURNAL OF CANCER
- Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients
- (2009) Evelyna Derhovanessian et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells
- (2009) K. A. Shafer-Weaver et al. JOURNAL OF IMMUNOLOGY
- Enhancing the efficacy of cancer vaccines in urologic oncology: new directions
- (2009) Sergei Kusmartsev et al. Nature Reviews Urology
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Human prostate-infiltrating CD8+T lymphocytes are oligoclonal and PD-1+
- (2009) Karen S. Sfanos et al. PROSTATE
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Therapeutic Management of De Novo Urological Malignancy in Renal Transplant Recipients: The Experience of the French Department of Urology and Kidney Transplantation from Bordeaux
- (2009) Hicham Elkentaoui et al. UROLOGY
- Solid cancers after allogeneic hematopoietic cell transplantation
- (2008) J. D. Rizzo et al. BLOOD
- CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
- (2008) B. Kavanagh et al. BLOOD
- The neovasculature homing motif NGR: more than meets the eye
- (2008) A. Corti et al. BLOOD
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD4+CD25+ Regulatory T Cells
- (2008) E. Degl'Innocenti et al. CANCER RESEARCH
- Tumor-Induced Immune Suppression of In vivo Effector T-Cell Priming Is Mediated by the B7-H1/PD-1 Axis and Transforming Growth Factor
- (2008) S. Wei et al. CANCER RESEARCH
- Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- -dependent mechanism
- (2008) A. Paone et al. CARCINOGENESIS
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Tumor-specific regulatory T cells in cancer patients
- (2008) Sytse J. Piersma et al. HUMAN IMMUNOLOGY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Transforming growth factor-β-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression
- (2008) Kerrilyn R Diener et al. LABORATORY INVESTIGATION
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
- PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
- (2008) C A Crane et al. ONCOGENE
- Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
- (2008) A. Bai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer
- (2008) Maria T.S. Bertilaccio et al. PROSTATE
- Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer
- (2008) Matteo Bellone et al. TRENDS IN IMMUNOLOGY
- Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?
- (2008) M.J. Resnick et al. UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search